Compounds > 2,4,6-trichlorophenylhydrazine
Page last updated: 2024-11-06

2,4,6-trichlorophenylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,6-trichlorophenylhydrazine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID79234
SCHEMBL ID1997250
MeSH IDM0193157

Synonyms (37)

Synonym
BB 0249759
(2,4,6-trichloro-phenyl)-hydrazine
einecs 226-217-2
unii-3arf2rvg9w
nsc 1869
3arf2rvg9w ,
5329-12-4
nsc1869
nsc-1869
hydrazine,4,6-trichlorophenyl)-
(2,6-trichlorophenyl)hydrazine
hydrazine, (2,4,6-trichlorophenyl)-
(2,4,6-trichlorophenyl)hydrazine
2,4,6-trichlorophenylhydrazine
inchi=1/c6h5cl3n2/c7-3-1-4(8)6(11-10)5(9)2-3/h1-2,11h,10h
AC-10674
AKOS000269017
STK893174
BBL012135
FT-0609855
AB01328055-02
SCHEMBL1997250
DTXSID5063780
2,4,6 trichlorophenylhydrazine
2,4,6-trichlorophenyl hydrazine
2,4,6-trichlorophenyl-hydrazine
2,4,6-trichloro phenylhydrazine
1-(2,4,6-trichlorophenyl)hydrazine
W-105755
1-(2,4,6-trichlorophenyl)hydrazine #
mfcd00025090
F15411
NCGC00335588-01
EN300-19589
STR00652
2.4.6-trichlorophenylhydrazine
CS-W015040
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.82 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
hydrazine
diamine : Any polyamine that contains two amino groups.		3.470azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
malondialdehyde
Malondialdehyde: The dialdehyde of malonic acid.. malonaldehyde : A dialdehyde that is propane substituted by two oxo groups at the terminal carbon atoms respectively. A biomarker of oxidative damage to lipids caused by smoking, it exists in vivo mainly in the enol form.		2.7130dialdehydebiomarker
1,1-diphenyl-2-picrylhydrazyl
1,1-diphenyl-2-picrylhydrazyl: A diphenyl picrate; the ability to decolorize this stable radical indicates reactivity of tested compounds (Banda, Anal Chem 46:1772-7 1974)		2.0710
4-hydroxy-2-nonenal
4-hydroxy-2-nonenal: cytotoxic product from peroxidation of liver microsomal lipids; RN given refers to cpd without isomeric designation. 4-hydroxynon-2-enal : An enal consisting of non-2-ene having an oxo group at the 1-position and a hydroxy group at the 4-position.. 4-hydroxynonenal : A monounsaturated fatty aldehyde that is nonanal that has undergone dehydrogenation to introduce a double bond at any position in the aliphatic chain and in which a hydrogen at position 4 has been replaced by a hydroxy group.		2.03104-hydroxynon-2-enal;
4-hydroxynonenal
ConditionIndicatedRelationship StrengthStudiesTrials
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		02.9340